Kowal Investment Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$603K Buy
5,806
+257
+5% +$26.2K 0.11% 103
2024
Q2
$538K Buy
5,549
+1
+0% +$92 0.11% 100
2024
Q1
$500K Buy
5,548
+2
+0% +$169 0.11% 102
2023
Q4
$442K Sell
5,546
-1
-0% -$75 0.1% 95
2023
Q3
$394K Sell
5,547
-179
-3% -$13.4K 0.11% 94
2023
Q2
$441K Buy
5,726
+191
+3% +$14.8K 0.12% 86
2023
Q1
$416K Sell
5,535
-25
-0.4% -$1.86K 0.12% 88
2022
Q4
$438K Buy
5,560
+10
+0.2% +$750 0.13% 88
2022
Q3
$390K Sell
5,550
-29
-0.5% -$2.27K 0.13% 82
2022
Q2
$447K Buy
5,579
+27
+0.5% +$2.11K 0.15% 68
2022
Q1
$421K Sell
5,552
-176
-3% -$13.9K 0.13% 71
2021
Q4
$489K Buy
5,728
+263
+5% +$20.5K 0.15% 59
2021
Q3
$413K Buy
5,465
+9
+0.2% +$715 0.13% 61
2021
Q2
$444K Buy
5,456
+1,436
+36% +$117K 0.16% 56
2021
Q1
$317K Sell
4,020
-100
-2% -$7.84K 0.13% 64
2020
Q4
$339K Buy
+4,120
New +$341K 0.16% 60

Other funds holding CL

Kowal Investment Group's CL Position: Q3 2024 in Review

Kowal Investment Group increased its Colgate-Palmolive (CL) stake by 4.6% in Q3 2024, buying an estimated $26.2K and bringing the position to 5,806 shares worth $603K. The position accounts for 0.11% of the portfolio, ranked #103.

Kowal Investment Group first reported a position in CL in Q4 2020 and has held it in 16 quarters since. 1,909 funds tracked by Wall St. Rank hold CL as of Q3 2024.

  • Kowal Investment Group held 5,806 shares of Colgate-Palmolive worth $603K as of Q3 2024.
  • Kowal Investment Group bought 257 Colgate-Palmolive shares in Q3 2024, an estimated $26.2K.
  • Colgate-Palmolive made up 0.11% of Kowal Investment Group's portfolio in Q3 2024, its #103 holding.
  • Kowal Investment Group first reported a position in Colgate-Palmolive in Q4 2020 and has held it in 16 quarters since.
  • 1,909 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2024.

Based on Kowal Investment Group's 13F filing for Q3 2024, filed 16 Oct 2024.